OKKO Health raises £900k to expand clinical trials and secure FDA approval for its eye monitoring app.
Seven members of Henley Business Angels contributed £145k as part of the overall investment.
OKKO Health develops digital health technology for monitoring visual function through mobile games. The platform helps clinicians track patient conditions between hospital visits.
OKKO Health has secured £900k in a funding round, which includes £145k from seven members of Henley Business Angels. The company has developed a digital application enabling patients to monitor eye health through gameplay between hospital appointments.
The capital will be directed towards expanding clinical trials, securing regulatory approval from the FDA, and initiating commercial sales. The raise follows a series of five grant awards from Innovate UK as the firm addresses growing strains on ophthalmology services.
From the founder
"I’m delighted to be taking investment from such a dynamic and engaged network – we are looking forward to harnessing the specific expertise of our investors as well as using the funding wisely to generate significant value over the year ahead."
Stephanie Campbell
CEO at OKKO Health
Investor perspective
"HBA found OKKO Health a truly innovative company, led by a qualified specialist who is delivering a solution that will see eye problems being detected earlier. This more effective treatment will bring real benefits to society."
Jurek Sikorski
Founder and Director, Henley Business Angels
Use of funds
- 01Continue product development
- 02Invest in sales and marketing
Investors
Categories
About the company
OKKO Health
OKKO Health develops a mobile game app that allows patients to self-monitor eye conditions between clinical appointments.